QL415
/ Qilu Pharma, QLSF Biotherapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 28, 2023
QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd. | Trial completion date: Dec 2023 ➔ Dec 2024 | Trial primary completion date: Dec 2022 ➔ Dec 2024
Metastases • Monotherapy • Trial completion date • Trial primary completion date • Oncology • Solid Tumor
August 29, 2022
QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1